Dr Reddy's announces launch of Sildenafil tablets
Agencies: Mumbai, Nov 19 2012, 15:51 IST
Pharma major Dr Reddy's Laboratories today announced that it has launched Sildenafil tablets, a bioequivalent generic version of Revatio (Sildenafil) tablets in the US market.
This followed the approval by the United States Food & Drug Administration (USFDA) of Dr Reddy's ANDA for Sildenafil tablets, a company statement said here.
The Revatio brand had US sales of approximately USD 338.67 million for the most recent twelve months ending September 2012, according to IMS Health.
Dr Reddy's Sildenafil tablets in 20 mg are available in 90 count bottle sizes, the release said.
Previous Story General Motors launches new Chevrolet Sail U-Va car Next Story Ernakulam dist to soon be 1st to achieve 100% banking
Reader's Comments| Post a Comment
Be the first to comment.
